# Shenfu Injection Improves Arterial Vascular Reactivity

> **NCT03749525** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Jianfeng Xie** · enrollment: 26 (estimated)

## Conditions studied

- Septic Shock
- Shenfu
- Vascular Reactivity

## Interventions

- **DRUG:** shenfu injection

## Key facts

- **NCT ID:** NCT03749525
- **Lead sponsor:** Jianfeng Xie
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2019-08
- **Final completion:** 2019-09
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03749525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03749525, "Shenfu Injection Improves Arterial Vascular Reactivity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03749525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
